DoD Prostate Cancer Population Science Impact Award | Apply Online

Opportunity Summary:

The DoD Prostate Cancer Research Program (PCRP) Population Science Impact Award (PSIA) is a funding opportunity from the Department of the Army (USAMRAA) designed to support high-impact population science research that can meaningfully reduce deaths from prostate cancer and/or improve quality of life for men living with the disease. This mechanism has evolved over time (previously offered as the Population Based Idea Development Award and Population Based Research Award), and it is positioned as a competitive, impact-driven program aimed at studies that can influence prostate cancer outcomes at the population level rather than through work focused only on individual patients. The announcement emphasizes that proposed projects should be strong enough to substantially advance the field and should clearly explain why the expected findings would matter for large groups of men, such as those represented in cohorts, health systems, or defined communities.

A central expectation is that applications align with the PCRP's overarching challenges or, if not, make a clear case that they address another critical prostate cancer research need. The program particularly encourages projects connected to several priority focus areas: biomarkers (especially those tied to aggressive disease), genetics and genomics, therapy and predictors of treatment response or resistance, and survivorship and palliative care. Research that addresses disparities in prostate cancer incidence, morbidity, or mortality is also explicitly encouraged, reflecting the program's interest in studies that can help explain and reduce unequal burdens of disease across populations.

The award is intended for systematic population-based studies grounded in established population science disciplines and methods. The announcement lists epidemiology, surveillance, health services research, outcomes research, behavioral science, social science, and dissemination research as relevant approaches, while leaving room for other population science frameworks. The goal is to generate data, evidence, and/or tools that are only feasible when studying groups at scale, such as identifying population-level risk patterns, evaluating real-world care and outcomes, understanding behavioral or social drivers of screening and treatment decisions, or testing strategies to spread effective practices across healthcare settings.

In terms of study design, the opportunity supports a range of population science methodologies, including retrospective studies, prospective studies, case-control designs, cohort studies, and other suitable approaches. The use of biospecimens and data from established retrospective databases is allowed, as long as the proposed sample size is large enough to support statistically significant findings. Reviewers are expected to look for a clearly articulated and conceptually sound hypothesis that is specific to prostate cancer, and for a study plan that demonstrates serious statistical rigor. Applicants are expected to spell out the statistical expertise on the research team and to present an analysis plan that makes it clear the team can appropriately handle population-level data, bias and confounding concerns, and the complexities of drawing valid conclusions from large datasets.

Human subjects research is permitted, but the opportunity explicitly restricts funded projects to studies that do not involve clinical trials. At the same time, the announcement allows correlative studies that use populations from existing clinical trials, meaning researchers can analyze already-generated clinical trial data or specimens to answer new population-oriented questions without conducting a new trial under this award. The announcement points applicants to CDMRP human subjects guidance materials for definitions and clarifications, which matters because CDMRP draws specific lines between clinical research, clinical trials, and other human subjects studies.

Applicants are also expected to show they can actually access the populations, samples, and datasets they propose to use. That includes providing documentation demonstrating access to appropriate patient populations, recruitment capability when applicable, and sufficient numbers of participants or records to achieve statistical significance. This emphasis on demonstrated access reflects the program's practical concern that population science projects can fail if they lack reliable pipelines to data, biospecimens, or community and health system partnerships.

To strengthen applications and encourage resource sharing, the PCRP suggests leveraging established PCRP-supported resources when relevant, including the Prostate Cancer Biorepository Network (PCBN) and the North Carolina-Louisiana Prostate Cancer Project (PCaP). These resources can be particularly useful for studies requiring retrospectively collected human specimens or linked clinical and demographic data, and they align with the program's preference for studies that can scale and generalize across real populations.

The award is offered as a Cooperative Agreement/Grant under CFDA 12.420 (Military Medical Research and Development). The posted opportunity (W81XWH-13-PCRP-PSIA) anticipated making about two awards, with an estimated total funding amount of $2.4 million and no cost sharing requirement. Eligibility is described as unrestricted, meaning a wide range of organizations may apply, subject to any additional clarifications in the full announcement.

Finally, the program signals an expectation of broad data and resource sharing. CDMRP states that data and research resources generated through funded projects should be made available to the wider research community, including consumer advocacy communities, and to the public, consistent with CDMRP guidance. In practice, this means applicants should be prepared to describe how they will manage, document, and share datasets, tools, and other products in ways that support transparency, reuse, and downstream impact beyond the original study team.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: DoD Prostate Cancer Postdoctoral Training Award

Previous opportunity: DoD Prostate Cancer Physician Research Training Award

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 13 PCRP PSIA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 13 PCRP PSIA) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 13 PCRP PSIA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.